Opko HealthOPK
About: OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Employees: 2,997
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
575% more call options, than puts
Call options by funds: $3.23M | Put options by funds: $479K
10.13% less ownership
Funds ownership: 35.98% [Q1] → 25.84% (-10.13%) [Q2]
11% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 63
14% less funds holding
Funds holding: 252 [Q1] → 217 (-35) [Q2]
33% less capital invested
Capital invested by funds: $401M [Q1] → $270M (-$130M) [Q2]
65% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 49
Research analyst outlook
We haven’t received any recent analyst ratings for OPK.
Financial journalist opinion
Based on 6 articles about OPK published over the past 30 days
